_utilizing-common-viruses-to-combat-dangerous-cancers-hear-from-the-leaders-at-theriva-therapeutics.jpg "Utilizing Common Viruses To Combat Dangerous Cancers - Hear From The Leaders At Theriva Therapeutics from baby vs injection Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 14:46
👁 View: 7.9M times
✓ Published: 26-Mar-2024
👁 View: 7.9M times
✓ Published: 26-Mar-2024
Description:
Theriva is developing highly differentiated oncolytic adenoviruses that are designed to overcome the challenges of accessibility, availability, and administration and can potentially enable multiple dosing to improve efficacy.<br/><br/>The unique therapeutic properties of Theriva’s oncolytic viruses represent a new class of cancer treatments that are designed to selectively destroy tumor cells and enhance the effects of current standard-of-care therapies. Engineered for systemic delivery, Theriva’s oncolytic viruses can be administered intravenously or as a direct injection into the tumor or tumor compartment (intratumoral, intravitreal).
Theriva is developing highly differentiated oncolytic adenoviruses that are designed to overcome the challenges of accessibility, availability, and administration and can potentially enable multiple dosing to improve efficacy.<br/><br/>The unique therapeutic properties of Theriva’s oncolytic viruses represent a new class of cancer treatments that are designed to selectively destroy tumor cells and enhance the effects of current standard-of-care therapies. Engineered for systemic delivery, Theriva’s oncolytic viruses can be administered intravenously or as a direct injection into the tumor or tumor compartment (intratumoral, intravitreal).
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_baby-vs-injection.webp "Vancouver Music Production")
_doctor-distracts-baby-from-her-shots-with-goofy-tune.webp "Daily Mail")
_worlds-fastest-porsche-hits-227mph.webp "For 15 years, BBI Autosport have been the experts in high-end, off-the-market tuning. But one of their most recent projects on a Porsche 911 GT2 RS seems to have stood out from the rest. Although this model is already Porsche’s most powerful car, BBI has expanded its capability even further by transforming one from a sleek sports car into a swift supercar. With specialist customisation, they pushed the car to reach speeds of 227mph, making it the fastest 911 in the world. Owner of BBI Betim Berisha told R.Rides: “We take this beautiful canvas that Porsche gives us and we tailor it to a client’s need or specific goal that we’re after. I don’t think we have ever built a car that made you actually feel this comfortable doing something so wrong. If I had to describe this Porsche in three words, I would say it’s visceral, raw and powerful.” Starting with the factory model, BBI upgraded the classic 911 with a custom engine, larger turbos and an advanced cooling system. Dmitriy Orlov, who works at the company said: “This car has bigger turbochargers, more intercooler, better calibration, a water-methanol injection system, better chassis to handle the high speed – and of course on Michelin tyres because they are just proven to be phenomenal at any speed and power level. There is also a lot of work on the interior. There are raised seats and harnesses to ensure that the car is safe.” To buy from the showroom, the Porsche 911 GT2 RS typically sells for around $350,000 – but with this level of modification, this car would cost closer to half a million dollars.")
_baby-18-months-vaccination-shot.webp "LookWhosBlogging Too")
_baby-vs-injection.jpg)
_doctor-distracts-baby-from-her-shots-with-goofy-tune.jpg)
_worlds-fastest-porsche-hits-227mph.jpg)
_baby-18-months-vaccination-shot.jpg)
![[+]](/images/menu.gif){kind=small}